Karyopharm Therapeutics, Inc. (KPTIQ)
0.0174
-0.02
(-56.50%)
USD |
OTCM |
Nov 10, 16:00
0.0163
0.00 (0.00%)
After-Hours: 20:00
Karyopharm Therapeutics Max Drawdown (5Y) : 99.85% for Oct. 31, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2026 | 99.85% |
| September 30, 2026 | 99.44% |
| August 31, 2026 | 99.16% |
| July 31, 2026 | 99.11% |
| June 30, 2026 | 99.07% |
| May 31, 2026 | 99.07% |
| April 30, 2026 | 99.07% |
| March 31, 2026 | 99.07% |
| February 28, 2026 | 99.07% |
| January 31, 2026 | 99.07% |
| December 31, 2025 | 99.07% |
| November 30, 2025 | 99.07% |
| October 31, 2025 | 99.07% |
| September 30, 2025 | 99.07% |
| August 31, 2025 | 99.07% |
| July 31, 2025 | 99.07% |
| June 30, 2025 | 99.07% |
| May 31, 2025 | 99.07% |
| April 30, 2025 | 99.07% |
| March 31, 2025 | 99.01% |
| February 28, 2025 | 98.09% |
| January 31, 2025 | 97.85% |
| December 31, 2024 | 97.85% |
| November 30, 2024 | 97.56% |
| October 31, 2024 | 97.56% |
| Date | Value |
|---|---|
| September 30, 2024 | 97.56% |
| August 31, 2024 | 97.56% |
| July 31, 2024 | 97.56% |
| June 30, 2024 | 97.56% |
| May 31, 2024 | 97.56% |
| April 30, 2024 | 97.56% |
| March 31, 2024 | 97.56% |
| February 29, 2024 | 97.56% |
| January 31, 2024 | 97.56% |
| December 31, 2023 | 97.56% |
| November 30, 2023 | 97.56% |
| October 31, 2023 | 97.11% |
| September 30, 2023 | 95.89% |
| August 31, 2023 | 95.38% |
| July 31, 2023 | 94.62% |
| June 30, 2023 | 93.54% |
| May 31, 2023 | 91.99% |
| April 30, 2023 | 91.26% |
| March 31, 2023 | 91.26% |
| February 28, 2023 | 91.26% |
| January 31, 2023 | 91.26% |
| December 31, 2022 | 91.26% |
| November 30, 2022 | 91.26% |
| October 31, 2022 | 91.26% |
| September 30, 2022 | 91.26% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Heron Therapeutics, Inc. | 98.16% |
| Tonix Pharmaceuticals Holding Corp. | 100.00% |
| Minerva Neurosciences, Inc. | 98.86% |
| Corbus Pharmaceuticals Holdings, Inc. | 99.24% |
| Ocugen, Inc. | 99.77% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -75.19 |
| Beta (5Y) | 1.156 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 96.27% |
| Historical Sharpe Ratio (5Y) | -0.6825 |
| Historical Sortino (5Y) | -1.069 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 44.91% |